Примери за използване на P-glycoprotein на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
P-glycoprotein.
In vitro studies with P-glycoprotein.
P-glycoprotein(P-gp).
Digoxin(substrate of p-Glycoprotein).
P-glycoprotein transporters.
It is also a substrate for P-glycoprotein.
Maraviroc inhibits P-glycoprotein in vitro(IC50 is 183 μM).
Emodepside is a substrate for P-glycoprotein.
Rilpivirine inhibits P-glycoprotein in vitro(IC50 is 9.2 μM).
Emodepside is a substrate for P-glycoprotein.
P-glycoprotein(mechanism by which active transportation is mediated).
Pomalidomide is also a substrate of P-glycoprotein in vitro.
Potent P-glycoprotein inhibitors such as ciclosporin and verapamil should also be avoided.
Spinosad has been shown to be a substrate for P-glycoprotein(PgP).
Avatrombopag is a substrate for P-glycoprotein(P-gp) mediated transport(see Table 3).
Methylthioninium chloride is a substrate of P-glycoprotein(P-gp).
Canagliflozin is transported by P-glycoprotein(P-gp) and Breast Cancer Resistance Protein(BCRP).
Maraviroc is a substrate for the efflux transporter P-glycoprotein.
Substances transported by P-glycoprotein or other transporters.
NNRTI, non-nucleoside reverse-transcriptase inhibitor; P-gp, P-glycoprotein.
Dabrafenib is a substrate of human P-glycoprotein(Pgp) and human BCRP in vitro.
Propranolol is a substrate for the intestinal efflux transporter, P-glycoprotein(P-gp).
Cobicistat inhibits the transporters p-glycoprotein(P-gp), BCRP, MATE1, OATP1B1 and OATP1B3.
Fluticasone furoate andvilanterol are both substrates of P-glycoprotein(P-gp).
Interaction with indinavir/ ritonavir not studied Ritonavir may modify P-glycoprotein mediated fexofenadine efflux when coadministered resulting in increased concentrations of fexofenadine.
In vitro studies demonstrated that neratinib is a substrate for P-glycoprotein(P-gp).
Concomitant treatment with CYP3A4 and P-glycoprotein(P-gp) inhibitors.
Based on these data, ISENTRESS is not expected to affect the pharmacokinetics of medicinal products that are substrates of these enzymes or P-glycoprotein.
Dexamethasone is transported by the P-glycoprotein(also known as MDR1).
Rimonabant displays high in vitro permeability andis not a substrate of P-glycoprotein.